MarketLens

What's Behind the Recent Insider Selling at AnaptysBio

4 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

What's Behind the Recent Insider Selling at Vicor

3 months ago

What's Behind the Recent Insider Selling at GigaCloud Technology

5 months ago

What's Behind the Recent Wave of Insider Selling at CoreWeave

5 months ago

What's Behind the Recent Insider Selling at CoreWeave (CRWV)

5 months ago

Why This MannKind Insider Stock Sale Matters Less Than a 9% Royalty at Risk

MannKind insider sold 65,808 shares (~$269K), representing 6% of direct holdings. The sale is overshadowed by a 9% royalty stream at risk.

MNKD

Stock News•2 months ago

Fresh Off IPO, A Director Buys $474,000 of Parabilis Medicines Stock. Is PBLS a Buy?

Parabilis Medicines (PBLS) director Alan Sebulsky bought $474K in stock at ~$27.06/share, raising his stake to 30,000 shares. The insider purchase signals confidence shortly after the IPO.

PBLS

Stock News•3 months ago

Biotech's Next Wave May Already be in Motion

The biotech and pharma sector is entering a pivotal growth phase driven by increased insider conviction, late-stage clinical successes, and emerging platform technologies. These factors are currently ...

NTHI

Stock News•3 months ago

AnaptysBio (ANAB) Surges 14.8%: Is This an Indication of Further Gains?

AnaptysBio (ANAB) shares rose 14.8% during the latest trading session on higher-than-average volume. Despite the price surge, recent downward trends in earnings estimate revisions may limit the stock'...

ANAB